8:00 a.m.	Welcome, Introductions
8:15 a.m.	The NIH Roadmap and Nanomedicine Development Centers
9:00 a.m.	Session I:  A Multidisciplinary Approach to Nanomedicine An example of a collaborative Nanomedicine team approach; understanding design principles for reverse engineering. Speakers:     Steve Goldstein, M.D., Ph.D., Yale University     Peter Agre, M.D., Johns Hopkins University     Hagan Bayley, Ph.D., University of Oxford, UK     Eric Jakobsson, Ph.D., NIGMS, University of Illinois
10:15 a.m.	Break
10:45 a.m.	Session II:  Targets for Nanomedicine Research An open, moderated discussion of additional examples of scientific areas for nanomedicine. Speakers:     Carlo Montemagno, Ph.D., UCLA     James Baker, M.D., University of Michigan
12 noon	Lunch
1:15 p.m.	Session III:  Creating Nanomedicine Research Teams A moderated discussion of strategies to establish Nanomedicine research teams. Panel members:     Chih-Ming Ho, Ph.D., CMISE/UCLA     Ueli Aebi, Ph.D., Biozentrum, University of Basel     Stuart Schreiber, Ph.D., HHMI, Harvard University     David Thomassen, Ph.D., US Department of Energy     Denice D. Denton, Ph.D., University of Washington
2:30 p.m.	Session IV:  Innovative Strategies for NIH Funding of Nanomedicine Application Process and Timeline New NIH funding authorities for Nanomedicine Final Discussion
4:00 p.m.	Adjournment